Evaluation of neoantigens in patients with NRAS mutated melanoma
Biomarker: BRAF and NRAS
Quality of Life Assessment Study in Patients with Metastatic Head and Neck Neoplasia submitted to Immunotherapy in Brazil – LACOG 0319